Company details


  • Print
  • Share Share

Valneva is a biotechnology company that specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. Valneva's mission is to use the power of innovation to excel in both antibody discovery and vaccines development and commercialization, by either in-house or in collaboration with industrial partners. It generates revenue from diversified sources from both its marketed product and current and new commercial partnerships. It has a portfolio of product candidates (in-house/partnered) and technology platforms that are becoming widely adopted by the biopharmaceutical industry at large.